CD8A and chronic myelogenous leukemia, BCR-ABL1 positive: Our results during CML and ovarian cancer are in favor of the existence of an axis composed of innate T cells with an antitumoral potential, which consist of iNKT cells and innate CD8(+) T lymphocytes.